Experimental hepatic encephalopathy causes early but sustained glial transcriptional changes

Abstract Hepatic encephalopathy (HE) is a common complication of liver cirrhosis, associated with high morbidity and mortality, for which no brain-targeted therapies exist at present. The interplay between hyperammonemia and inflammation is thought to drive HE development. As such, astrocytes, the m...

Full description

Bibliographic Details
Main Authors: Wouter Claeys, Lien Van Hoecke, Hannah Lernout, Clint De Nolf, Griet Van Imschoot, Elien Van Wonterghem, Daan Verhaege, Jonas Castelein, Anja Geerts, Christophe Van Steenkiste, Roosmarijn E. Vandenbroucke
Format: Article
Language:English
Published: BMC 2023-05-01
Series:Journal of Neuroinflammation
Online Access:https://doi.org/10.1186/s12974-023-02814-w
_version_ 1797811352463474688
author Wouter Claeys
Lien Van Hoecke
Hannah Lernout
Clint De Nolf
Griet Van Imschoot
Elien Van Wonterghem
Daan Verhaege
Jonas Castelein
Anja Geerts
Christophe Van Steenkiste
Roosmarijn E. Vandenbroucke
author_facet Wouter Claeys
Lien Van Hoecke
Hannah Lernout
Clint De Nolf
Griet Van Imschoot
Elien Van Wonterghem
Daan Verhaege
Jonas Castelein
Anja Geerts
Christophe Van Steenkiste
Roosmarijn E. Vandenbroucke
author_sort Wouter Claeys
collection DOAJ
description Abstract Hepatic encephalopathy (HE) is a common complication of liver cirrhosis, associated with high morbidity and mortality, for which no brain-targeted therapies exist at present. The interplay between hyperammonemia and inflammation is thought to drive HE development. As such, astrocytes, the most important ammonia-metabolizing cells in the brain, and microglia, the main immunomodulatory cells in the brain, have been heavily implicated in HE development. As insight into cellular perturbations driving brain pathology remains largely elusive, we aimed to investigate cell-type specific transcriptomic changes in the HE brain. In the recently established mouse bile duct ligation (BDL) model of HE, we performed RNA-Seq of sorted astrocytes and microglia at 14 and 28 days after induction. This revealed a marked transcriptional response in both cell types which was most pronounced in microglia. In both cell types, pathways related to inflammation and hypoxia, mechanisms commonly implicated in HE, were enriched. Additionally, astrocytes exhibited increased corticoid receptor and oxidative stress signaling, whereas microglial transcriptome changes were linked to immune cell attraction. Accordingly, both monocytes and neutrophils accumulated in the BDL mouse brain. Time-dependent changes were limited in both cell types, suggesting early establishment of a pathological phenotype. While HE is often considered a unique form of encephalopathy, astrocytic and microglial transcriptomes showed significant overlap with previously established gene expression signatures in other neuroinflammatory diseases like septic encephalopathy and stroke, suggesting common pathophysiological mechanisms. Our dataset identifies key molecular mechanisms involved in preclinical HE and provides a valuable resource for development of novel glial-directed therapeutic strategies. Graphical Abstract
first_indexed 2024-03-13T07:22:26Z
format Article
id doaj.art-941f27bb31d8449898228eaff89de72f
institution Directory Open Access Journal
issn 1742-2094
language English
last_indexed 2024-03-13T07:22:26Z
publishDate 2023-05-01
publisher BMC
record_format Article
series Journal of Neuroinflammation
spelling doaj.art-941f27bb31d8449898228eaff89de72f2023-06-04T11:34:48ZengBMCJournal of Neuroinflammation1742-20942023-05-0120112010.1186/s12974-023-02814-wExperimental hepatic encephalopathy causes early but sustained glial transcriptional changesWouter Claeys0Lien Van Hoecke1Hannah Lernout2Clint De Nolf3Griet Van Imschoot4Elien Van Wonterghem5Daan Verhaege6Jonas Castelein7Anja Geerts8Christophe Van Steenkiste9Roosmarijn E. Vandenbroucke10Hepatology Research Unit, Department of Internal Medicine and Paediatrics, Ghent UniversityBarriers in Inflammation, VIB Center for Inflammation Research, VIBBarriers in Inflammation, VIB Center for Inflammation Research, VIBBarriers in Inflammation, VIB Center for Inflammation Research, VIBBarriers in Inflammation, VIB Center for Inflammation Research, VIBBarriers in Inflammation, VIB Center for Inflammation Research, VIBBarriers in Inflammation, VIB Center for Inflammation Research, VIBBarriers in Inflammation, VIB Center for Inflammation Research, VIBHepatology Research Unit, Department of Internal Medicine and Paediatrics, Ghent UniversityDepartment of Gastroenterology and Hepatology, Antwerp UniversityBarriers in Inflammation, VIB Center for Inflammation Research, VIBAbstract Hepatic encephalopathy (HE) is a common complication of liver cirrhosis, associated with high morbidity and mortality, for which no brain-targeted therapies exist at present. The interplay between hyperammonemia and inflammation is thought to drive HE development. As such, astrocytes, the most important ammonia-metabolizing cells in the brain, and microglia, the main immunomodulatory cells in the brain, have been heavily implicated in HE development. As insight into cellular perturbations driving brain pathology remains largely elusive, we aimed to investigate cell-type specific transcriptomic changes in the HE brain. In the recently established mouse bile duct ligation (BDL) model of HE, we performed RNA-Seq of sorted astrocytes and microglia at 14 and 28 days after induction. This revealed a marked transcriptional response in both cell types which was most pronounced in microglia. In both cell types, pathways related to inflammation and hypoxia, mechanisms commonly implicated in HE, were enriched. Additionally, astrocytes exhibited increased corticoid receptor and oxidative stress signaling, whereas microglial transcriptome changes were linked to immune cell attraction. Accordingly, both monocytes and neutrophils accumulated in the BDL mouse brain. Time-dependent changes were limited in both cell types, suggesting early establishment of a pathological phenotype. While HE is often considered a unique form of encephalopathy, astrocytic and microglial transcriptomes showed significant overlap with previously established gene expression signatures in other neuroinflammatory diseases like septic encephalopathy and stroke, suggesting common pathophysiological mechanisms. Our dataset identifies key molecular mechanisms involved in preclinical HE and provides a valuable resource for development of novel glial-directed therapeutic strategies. Graphical Abstracthttps://doi.org/10.1186/s12974-023-02814-w
spellingShingle Wouter Claeys
Lien Van Hoecke
Hannah Lernout
Clint De Nolf
Griet Van Imschoot
Elien Van Wonterghem
Daan Verhaege
Jonas Castelein
Anja Geerts
Christophe Van Steenkiste
Roosmarijn E. Vandenbroucke
Experimental hepatic encephalopathy causes early but sustained glial transcriptional changes
Journal of Neuroinflammation
title Experimental hepatic encephalopathy causes early but sustained glial transcriptional changes
title_full Experimental hepatic encephalopathy causes early but sustained glial transcriptional changes
title_fullStr Experimental hepatic encephalopathy causes early but sustained glial transcriptional changes
title_full_unstemmed Experimental hepatic encephalopathy causes early but sustained glial transcriptional changes
title_short Experimental hepatic encephalopathy causes early but sustained glial transcriptional changes
title_sort experimental hepatic encephalopathy causes early but sustained glial transcriptional changes
url https://doi.org/10.1186/s12974-023-02814-w
work_keys_str_mv AT wouterclaeys experimentalhepaticencephalopathycausesearlybutsustainedglialtranscriptionalchanges
AT lienvanhoecke experimentalhepaticencephalopathycausesearlybutsustainedglialtranscriptionalchanges
AT hannahlernout experimentalhepaticencephalopathycausesearlybutsustainedglialtranscriptionalchanges
AT clintdenolf experimentalhepaticencephalopathycausesearlybutsustainedglialtranscriptionalchanges
AT grietvanimschoot experimentalhepaticencephalopathycausesearlybutsustainedglialtranscriptionalchanges
AT elienvanwonterghem experimentalhepaticencephalopathycausesearlybutsustainedglialtranscriptionalchanges
AT daanverhaege experimentalhepaticencephalopathycausesearlybutsustainedglialtranscriptionalchanges
AT jonascastelein experimentalhepaticencephalopathycausesearlybutsustainedglialtranscriptionalchanges
AT anjageerts experimentalhepaticencephalopathycausesearlybutsustainedglialtranscriptionalchanges
AT christophevansteenkiste experimentalhepaticencephalopathycausesearlybutsustainedglialtranscriptionalchanges
AT roosmarijnevandenbroucke experimentalhepaticencephalopathycausesearlybutsustainedglialtranscriptionalchanges